newsfilter
← Latest News
Business Wire·

Eleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination Agreement

Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II ("Silver Spike II" or "SPKB") (NASDAQ:SPKB), a publicly traded special purpose acquisition company ("SPAC